INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

73,160 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
GA
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
TBPHTheravance Biopharma, Inc.
Disposition to issuer
D—
23.4K sh
Sep 23, 2026Sep 24, 2026
Page 347 of 1829
← PrevNext →
traded Sep 23, 2026
+1d
SEC Form 4

Evidence

9
NJ
Nallen JohnPresident, COO
FOXFox Corp
Grant or award
A—
180 sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
HD
Hankin Michael DavidDirector
SWKSTANLEY BLACK & DECKER, INC.
Grant or award
A$12K
132 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC Form 4

Evidence

9
BE
Boatman Jonathon E.SVP - Chief Legal Officer
RALRalliant Corp
Grant or award
A$105
2 sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
CC
Carey ChaseDirector
FOXFox Corp
Grant or award
A$7,611
119 sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
SL
Schneider Andrea LPres & CEO Horizon Airlines
ALKALASKA AIR GROUP, INC.
Option exercise
M—
499 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC Form 4

Evidence

9
SA
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
TBPHTheravance Biopharma, Inc.
Disposition to issuer
D—
108.4K sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
TN
Thaung NicoleChief Financial Officer
STKSONE Group Hospitality, Inc.
Tax withholding
F$8,830
5,384 sh
Sep 24, 2026Sep 24, 2026
traded Sep 24, 2026
+0dSEC Form 4

Evidence

9
TL
Tyson William LDirector
CULPCULP INC
Option exercise
M—
13.2K sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
MV
Mitchell Adrian VDirector
SWKSTANLEY BLACK & DECKER, INC.
Grant or award
A$31K
343 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC Form 4

Evidence

9
BA
Burck William ADirector
FOXFox Corp
Grant or award
A$7,611
119 sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
JW
Jackman WorthingDirector
ODFLOLD DOMINION FREIGHT LINE, INC.
Grant or award
A—
545 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC Form 4

Evidence

9
GS
Gray SusannahDirector
TBPHTheravance Biopharma, Inc.
Disposition to issuer
D—
24.3K sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
AJ
Abbott Anthony JDirector
FOXFox Corp
Grant or award
A$4,221
66 sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
Murdoch Lachlan KDirector, Executive Chair, CEO
FOXFox Corp
Grant or award
A—
781 sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
GS
Gray SusannahDirector
TBPHTheravance Biopharma, Inc.
Disposition to issuer
D—
22.0K sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
HL
Holt Donald LeroyChief Acctg. Off. & Controller
LUMNLumen Technologies, Inc.
Tax withholding
F$16K
2,538 sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
MV
Mitchell Adrian VDirector
SWKSTANLEY BLACK & DECKER, INC.
Grant or award
A$10K
114 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC Form 4

Evidence

9
WM
Wilson MarkDirector
CULPCULP INC
Grant or award
A—
12.9K sh
Sep 24, 2026Sep 24, 2026
traded Sep 24, 2026
+0dSEC Form 4

Evidence

9
LA
Laschinger Mary ADirector
SWKSTANLEY BLACK & DECKER, INC.
Grant or award
A$2,208
24 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC Form 4

Evidence

9
GS
Gray SusannahDirector
TBPHTheravance Biopharma, Inc.
Disposition to issuer
D—
23.6K sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
BM
Bobek Therese MDirector
MEIMETHODE ELECTRONICS INC
Grant or award
A—
9,186 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC Form 4

Evidence

9
SA
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
TBPHTheravance Biopharma, Inc.
Disposition to issuer
D—
23.4K sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
JL
Johnson Margaret LDirector
FOXFox Corp
Grant or award
A$4,221
66 sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
UL
Ullrich LarsSVP Global Automotive Business
MEIMETHODE ELECTRONICS INC
Grant or award
A—
27.6K sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC Form 4

Evidence

9
MA
Miller AineSVP, DEV & HEAD OF IRE OFFICE
TBPHTheravance Biopharma, Inc.
Disposition to issuer
D—
37.5K sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
LA
Lindsey Mary ADirector
MEIMETHODE ELECTRONICS INC
Grant or award
A—
9,186 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC Form 4

Evidence

9
BM
Berry Jason MEVP & Chief Operating Officer
ALKALASKA AIR GROUP, INC.
Option exercise
M—
2,010 sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
HD
Hankin Michael DavidDirector
SWKSTANLEY BLACK & DECKER, INC.
Grant or award
A$13K
138 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC Form 4

Evidence

9
SL
Schneider Andrea LPres & CEO Horizon Airlines
ALKALASKA AIR GROUP, INC.
Option exercise
M—
48 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC Form 4

Evidence

9
TS
Tomsic StevenChief Financial Officer
FOXFox Corp
Grant or award
A—
156 sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
GA
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
TBPHTheravance Biopharma, Inc.
Disposition to issuer
D—
223.9K sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
MV
Mitchell Adrian VDirector
SWKSTANLEY BLACK & DECKER, INC.
Grant or award
A$5,893
65 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC Form 4

Evidence

9
TL
Tyson William LDirector
CULPCULP INC
Grant or award
A—
14.1K sh
Sep 24, 2026Sep 24, 2026
traded Sep 24, 2026
+0dSEC Form 4

Evidence

9
GA
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
TBPHTheravance Biopharma, Inc.
Disposition to issuer
D—
107.8K sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
SS
Schulz StacieChief Accounting Officer
MEIMETHODE ELECTRONICS INC
Grant or award
A—
4,922 sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC Form 4

Evidence

9
BJ
Barton III Alvin JamesEVP Commercial Growth & Ops.
NPKINPK International Inc.
Grant or award
A—
12.8K sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC Form 4

Evidence

9
BC
Baker CaryCHIEF FINANCIAL OFFICER
PIIMPINJ INC
Option exercise
M—
596 sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
HS
Hulse Walter S IiiSee Remarks
OKEONEOK INC /NEW/
Option exercise
M—
7,238 sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence

9
SA
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
TBPHTheravance Biopharma, Inc.
Disposition to issuer
D—
205.0K sh
Sep 23, 2026Sep 24, 2026
traded Sep 23, 2026
+1dSEC Form 4

Evidence